NCT07132554

Brief Summary

Background: Exercise-based cardiac rehabilitation is recommended early to very early for heart transplant recipients (HTRs), but data on its feasibility and efficacy at this stage are lacking. Primarily, this study reports the results of an intensive program combining moderate-intensity continuous-training (MICT) and high-intensity interval-training (HIIT) in early HTRs. Secondarily, it explores the determinants of VO2peak in this population. Methods: A single-center retrospective study of a prospectively-collected database including patients who were consecutively referred to a cardiac rehabilitation unit immediately after discharge from acute post-transplant care, between December 2012 and December 2024. Patients participated in a tailored program combining MICT and HIIT as soon as they could cycle, and performed a first cardiopulmonary exercise test (CPET1) when possible. The initial prescription included 32 planned 30-minute (±5) aerobic sessions for 4 weeks, on a standard or semi-recumbent cycle-ergometer, twice a day (4 days a week) including one session of MICT (PVT and Borg-RPE 12-14) and one session of HIIT (6-8 x 1':3'/ PAT and Borg-RPE ≥ 15), plus additional sessions (respiratory and strengthening physiotherapy, gymnastics or walking, occupational therapy). The primary outcome was improvement in exercise capacity, measured by maximal oxygen consumption (VO2peak) between CPET1 and discharge (CPET2). Secondary outcomes included feasibility criterions (exercise-related adverse events-AE, and completion rates), then clinical, biological and echocardiographic parameters influencing exercise capacity.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
510

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2012

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
12.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 22, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 20, 2025

Completed
Last Updated

August 20, 2025

Status Verified

August 1, 2025

Enrollment Period

12.1 years

First QC Date

July 22, 2025

Last Update Submit

August 17, 2025

Conditions

Keywords

Exercise-based cardiac rehabilitationVO2peakCombine Moderate and Intense TrainingEarly-to-very-early phase post-HTxExercise capacity determinants

Outcome Measures

Primary Outcomes (1)

  • VO2peak

    Main determinant of Exercise capacity, measured during a symptom-limited CardioPulmonary Exercise Test (CPET), performed in routine at our cardiac rehabilitation department

    Baseline (Week 1) Discharge (Week 5)

Secondary Outcomes (11)

  • VO2 vt/at

    Baseline (Week 1) Discharge (Week 5)

  • Heart rate

    Baseline (Week 1) Discharge (Week 5)

  • Power output

    Baseline (Week 1) Discharge (Week 5)

  • O2pulse

    Baseline (Week 1) Discharge (Week 5)

  • Echocardiography parameters

    Baseline (Week 1) Discharge (Week 5)

  • +6 more secondary outcomes

Interventions

Combining 1:1 MICT and HIIT in short (4 weeks) high-volume (32 sessions) early-to-very-early phase program post heart transplantation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

De novo HTR, after Heart failure from any etiology, at any age, from 3 University Transplantation units in the south-eastern quarter of France, admitted in our rehabilitation center for cardiac rehabilitation

You may qualify if:

  • De Novo Heart Transplant Recipients (HTR)

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific coordinator

Study Record Dates

First Submitted

July 22, 2025

First Posted

August 20, 2025

Study Start

December 1, 2012

Primary Completion

December 31, 2024

Study Completion

June 30, 2025

Last Updated

August 20, 2025

Record last verified: 2025-08